Assessment of P2Y12 inhibition with the point-of-care device VerifyNow P2Y12 in patients treated with prasugrel or clopidogrel coadministered with aspirin-Reference-Cited by-同舟云学术

Assessment of P2Y12 inhibition with the point-of-care device VerifyNow P2Y12 in patients treated with prasugrel or clopidogrel coadministered with aspirin

Published:2009-03 Issue:3 Volume:157 Page:562.e1-562.e9
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Varenhorst Christoph,James Stefan,Erlinge David,Braun Oscar Ö.,Brandt John T.,Winters Kenneth J.,Jakubowski Joseph A.,Olofsson Sylvia,Wallentin Lars,Siegbahn Agneta

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference40 articles.

1. Double-Blind Study of the Safety of Clopidogrel With and Without a Loading Dose in Combination With Aspirin Compared With Ticlopidine in Combination With Aspirin After Coronary Stenting

2. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

3. Guidelines for the diagnosis and treatment of non–ST-segment elevation acute coronary syndromes;Task Force for Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of European Society of Cardiology;Eur Heart J,2007

4. Clopidogrel resistance?;Gurbel;Thromb Res,2007

5. Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement;Hochholzer;J Am Coll Cardiol,2006

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Time-dependent changes in P2Y12 reaction unit values for predicting the different types of cardiovascular events in patients with ischemic heart disease;Heart and Vessels;2023-06-15

2. P2Y12 reaction units and ischemic and bleeding events after neuro-endovascular treatment;Journal of Stroke and Cerebrovascular Diseases;2022-09

3. Thrombosis and Coagulopathy;Acute Care Neurosurgery by Case Management;2022

4. Candidate Gene of NOS3, MMP3, AGT, and AGT1R and Pathway Analyses for Platelet Reactivity and Clinical Outcomes of Repeat Revascularization After First PCI in Chinese Patients;Cardiovascular Drugs and Therapy;2021-12-03

5. Application of Auxiliary VerifyNow Point-of-Care Assays to Assess the Pharmacodynamics of RUC-4, a Novel αIIbβ3 Receptor Antagonist;TH Open;2021-07